Publications

Recently Accepted Papers

• Frailty as a Modifier of Antihypertensive Treatment Benefit: Toward Precision Medicine in Older Adults
  Pasquale Mone, Gaetano Santulli
  LANCET. 2026. In press.
• Manipulation of ER-mitochondria interactions with mitofusin modulators to reduce cardiac damage during myocardial infarction
  Joshua L. Axelrod, Zuzana Nichtova, Timothy Schneider, Jaehoon Lee, Ryan Pekson, Dongze Qin, Madeeha Ghazi, Vinay Kumar, Victoria Margulets, Lorrie A. Kirshenbaum, Gaetano Santulli, Gyorgy G. Csordas, John W. Calvert, Richard N. Kitsis
  NATURE CARDIOVASCULAR RESEARCH. In press.
• Beyond glucose lowering and ketogenesis: Unveiling new cardioprotective metabolic mechanisms of SGLT2 inhibitors
  Alessia Riccio, Gaetano Santulli
  NATURE REVIEWS CARDIOLOGY. 2026. In press.
• Dapagliflozin attenuates progression from pre-frailty to frailty in patients with hypertension and chronic kidney disease
  Pasquale Mone, Davide Viggiano, Antonella Pansini, Maria Virginia Soldovieri, Giada Sabatelli, Valeria Visco, Gaetano Macina, Eugenio Boccalone, Michele Ciccarelli, Giuseppe Martinelli, Marco Di Mauro, Carmine Vecchione, Maria Morgante, Fahimeh Varzideh, Germano Guerra, Gaetano Santulli
  JOURNAL OF CLINICAL INVESTIGATION. 2026. In press.